Position in XGN
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$710,205
-$469,533 QoQ
Shares Held
236,735
+22.0% QoQ
Ownership
0.980%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in XGN Over Time
Shares Held
Position Value (USD)
Derivatives in XGN
reported options exposure · as of Dec 31, 2025CallValue
$92,416
CallShares
15,200
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026JANE STREET GROUP, LLC holds $138,902,025 across 28 Diagnostics & Research names. XGN ranks #19 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NTRA |
Natera, Inc.
|
263,677 | $52,732,762 | |
| 2 | TWST |
Twist Bioscience Corp
|
601,163 | $28,567,265 | |
| 3 | TMO |
Thermo Fisher Scientific Inc.
|
17,167 | $8,438,095 | |
| 4 | IDXX |
Idexx Laboratories Inc /De
|
14,998 | $8,427,225 | |
| 5 | A |
Agilent Technologies, Inc.
|
60,577 | $6,904,565 | |
| 6 | QGEN |
Qiagen N.V.
|
160,639 | $6,431,985 | |
| 7 | MYGN |
Myriad Genetics Inc
|
1,202,531 | $5,411,389 | |
| 8 | CDNA |
CareDx, Inc.
|
250,351 | $4,346,092 |
All Filings in XGN
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $710,205 | 236,735 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $1,179,738 | 194,036 | Shares | Defined | 2026-02-12 | |
| 2025-12-31 | $92,416 | 15,200 | Call | Defined | 2026-02-12 | |
| 2025-09-30 | $129,682 | 11,800 | Call | Defined | 2025-11-14 | |
| 2025-09-30 | $1,124,353 | 102,307 | Shares | Defined | 2025-11-14 | |
| No filing history on record for this holder in this stock. | ||||||